•
Jun 30, 2021

Avidity Biosciences Q2 2021 Earnings Report

Total Revenue
$2.61M
Previous year: $1.54M
+69.2%
EPS
-$0.7
Previous year: -$1.23
-43.1%
Gross Profit
-$20.1M
Cash and Equivalents
$276M
Free Cash Flow
-$28.8M
Total Assets
$291M

Avidity Biosciences

Avidity Biosciences